Tdap vaccine and pregnancy. Why is itimportant? Safety and efficacy of thevaccine
Descripción del Articulo
Pertussis (Bordetella pertussis) is a highly contagious respiratory disease that poses a significant threat to infants under six months of age, in whom clinical manifestations may be atypical and complications severe or fatal, including apnea, pneumonia, encephalopathy, and death. Despite the availa...
| Autor: | |
|---|---|
| Formato: | artículo |
| Fecha de Publicación: | 2025 |
| Institución: | Sociedad Peruana de Obstetricia y Ginecología |
| Repositorio: | Revista Peruana de Ginecología y Obstetricia |
| Lenguaje: | español inglés |
| OAI Identifier: | oai:ginecologiayobstetricia.pe:article/2773 |
| Enlace del recurso: | https://ginecologiayobstetricia.pe/index.php/RPGO/article/view/2773 |
| Nivel de acceso: | acceso abierto |
| Materia: | Whooping cough Pertussis Bordetella pertussis Tdap vaccine Maternal vaccination Tos ferina Vacuna Tdap Vacunación en el embarazo |
| id |
REVSPOG_1c3f8b002eef956a043662ea164f69e3 |
|---|---|
| oai_identifier_str |
oai:ginecologiayobstetricia.pe:article/2773 |
| network_acronym_str |
REVSPOG |
| network_name_str |
Revista Peruana de Ginecología y Obstetricia |
| repository_id_str |
. |
| dc.title.none.fl_str_mv |
Tdap vaccine and pregnancy. Why is itimportant? Safety and efficacy of thevaccine Vacuna Tdap y embarazo. ¿Porque es importante su administración?. Seguridad y eficacia de la vacuna |
| title |
Tdap vaccine and pregnancy. Why is itimportant? Safety and efficacy of thevaccine |
| spellingShingle |
Tdap vaccine and pregnancy. Why is itimportant? Safety and efficacy of thevaccine Namizato Ikemiyashiro, Claudia Sofia Whooping cough Pertussis Bordetella pertussis Tdap vaccine Maternal vaccination Tos ferina Bordetella pertussis Vacuna Tdap Vacunación en el embarazo |
| title_short |
Tdap vaccine and pregnancy. Why is itimportant? Safety and efficacy of thevaccine |
| title_full |
Tdap vaccine and pregnancy. Why is itimportant? Safety and efficacy of thevaccine |
| title_fullStr |
Tdap vaccine and pregnancy. Why is itimportant? Safety and efficacy of thevaccine |
| title_full_unstemmed |
Tdap vaccine and pregnancy. Why is itimportant? Safety and efficacy of thevaccine |
| title_sort |
Tdap vaccine and pregnancy. Why is itimportant? Safety and efficacy of thevaccine |
| dc.creator.none.fl_str_mv |
Namizato Ikemiyashiro, Claudia Sofia Namizato Ikemiyashiro, Claudia Sofia |
| author |
Namizato Ikemiyashiro, Claudia Sofia |
| author_facet |
Namizato Ikemiyashiro, Claudia Sofia |
| author_role |
author |
| dc.subject.none.fl_str_mv |
Whooping cough Pertussis Bordetella pertussis Tdap vaccine Maternal vaccination Tos ferina Bordetella pertussis Vacuna Tdap Vacunación en el embarazo |
| topic |
Whooping cough Pertussis Bordetella pertussis Tdap vaccine Maternal vaccination Tos ferina Bordetella pertussis Vacuna Tdap Vacunación en el embarazo |
| description |
Pertussis (Bordetella pertussis) is a highly contagious respiratory disease that poses a significant threat to infants under six months of age, in whom clinical manifestations may be atypical and complications severe or fatal, including apnea, pneumonia, encephalopathy, and death. Despite the availability of effective vaccines for decades, pertussis continues to be a public health problem, with recurring epidemic cycles.Since the childhood vaccination schedule is not completed until six months of age, newborns and infants remain vulnerable. Tdap vaccination during pregnancy has been shown to be an effective and safe strategy for preventing the disease at this stage. Administering the vaccine between 20 and 36 weeks of gestation—preferably at least two weeks before delivery—ensures adequate transplacental transfer of antibodies, conferring passive protection to the newborn. Numerous observationalstudies and meta-analyses have shown significant reductions in hospitalizations, severe illness, and mortality in infants born to vaccinated mothers. Likewise, no significant maternal, obstetric, or neonatal risks have been observed. Nor has maternal vaccination been shown to clinically interfere with the infant's immune response after receiving their own vaccination schedule. Vaccination coverage among pregnant women in Peru is still suboptimal, highlighting the need for health personnel to commit to recommending and implementing this intervention in every pregnancy as an integral part of prenatal care. |
| publishDate |
2025 |
| dc.date.none.fl_str_mv |
2025-11-13 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://ginecologiayobstetricia.pe/index.php/RPGO/article/view/2773 10.31403/rpgo.v71i2790 |
| url |
https://ginecologiayobstetricia.pe/index.php/RPGO/article/view/2773 |
| identifier_str_mv |
10.31403/rpgo.v71i2790 |
| dc.language.none.fl_str_mv |
spa eng |
| language |
spa eng |
| dc.relation.none.fl_str_mv |
https://ginecologiayobstetricia.pe/index.php/RPGO/article/view/2773/3053 https://ginecologiayobstetricia.pe/index.php/RPGO/article/view/2773/3054 |
| dc.rights.none.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
Sociedad Peruana de Obstetricia y Ginecología |
| publisher.none.fl_str_mv |
Sociedad Peruana de Obstetricia y Ginecología |
| dc.source.none.fl_str_mv |
The Peruvian Journal of Gynecology and Obstetrics ; Vol. 71 No. 2 (2025) Revista Peruana de Ginecología y Obstetricia; Vol. 71 Núm. 2 (2025) 2304-5132 2304-5124 10.31403/rpgo.v71i reponame:Revista Peruana de Ginecología y Obstetricia instname:Sociedad Peruana de Obstetricia y Ginecología instacron:SPOG |
| instname_str |
Sociedad Peruana de Obstetricia y Ginecología |
| instacron_str |
SPOG |
| institution |
SPOG |
| reponame_str |
Revista Peruana de Ginecología y Obstetricia |
| collection |
Revista Peruana de Ginecología y Obstetricia |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1868078739572654080 |
| spelling |
Tdap vaccine and pregnancy. Why is itimportant? Safety and efficacy of thevaccineVacuna Tdap y embarazo. ¿Porque es importante su administración?. Seguridad y eficacia de la vacunaNamizato Ikemiyashiro, Claudia Sofia Namizato Ikemiyashiro, Claudia Sofia Whooping coughPertussisBordetella pertussisTdap vaccineMaternal vaccinationTos ferinaBordetella pertussisVacuna TdapVacunación en el embarazoPertussis (Bordetella pertussis) is a highly contagious respiratory disease that poses a significant threat to infants under six months of age, in whom clinical manifestations may be atypical and complications severe or fatal, including apnea, pneumonia, encephalopathy, and death. Despite the availability of effective vaccines for decades, pertussis continues to be a public health problem, with recurring epidemic cycles.Since the childhood vaccination schedule is not completed until six months of age, newborns and infants remain vulnerable. Tdap vaccination during pregnancy has been shown to be an effective and safe strategy for preventing the disease at this stage. Administering the vaccine between 20 and 36 weeks of gestation—preferably at least two weeks before delivery—ensures adequate transplacental transfer of antibodies, conferring passive protection to the newborn. Numerous observationalstudies and meta-analyses have shown significant reductions in hospitalizations, severe illness, and mortality in infants born to vaccinated mothers. Likewise, no significant maternal, obstetric, or neonatal risks have been observed. Nor has maternal vaccination been shown to clinically interfere with the infant's immune response after receiving their own vaccination schedule. Vaccination coverage among pregnant women in Peru is still suboptimal, highlighting the need for health personnel to commit to recommending and implementing this intervention in every pregnancy as an integral part of prenatal care.La tos ferina (Bordetella pertussis) es una enfermedad respiratoria altamente contagiosa que representa una amenaza significativa para los lactantes menores de seis meses, en quienes las manifestaciones clínicas pueden ser atípicas y las complicaciones graves o letales, incluyendo apnea, neumonía, encefalopatía y muerte. A pesar de la disponibilidad de vacunas eficaces desde hace décadas, la tos ferina continúa siendo un problema de salud pública, con ciclos epidémicos recurrentes. Dado que el esquema de vacunación infantil no se completa sino hasta los seis meses, los recién nacidos y lactantes permanecen vulnerables. La vacunación con Tdap durante el embarazo ha demostrado ser una estrategia eficaz y segura para prevenir la enfermedad en esta etapa. Al administrar la vacuna entre las semanas 20 y 36 de gestación —preferentemente al menos dos semanas antes del parto— se logra una adecuada transferencia transplacentaria de anticuerpos, confiriendo protección pasiva al neonato. Numerosos estudios observacionales y metaanálisis han evidenciado reducciones significativas en hospitalizaciones, enfermedad gravey mortalidad en lactantes nacidos de madres vacunadas. Asimismo, no se han observado riesgos significativos maternos, obstétricos ni neonatales relevantes.Tampoco se ha demostrado que la vacunación materna interfiera clínicamente con la respuesta inmunitaria del lactante tras recibir su propio esquema de vacunación.La cobertura vacunal en gestantes en el Perú aún es subóptima, lo que resalta la necesidad del compromiso del personal de salud para recomendar e implementar esta intervención en cada embarazo, como parte integral del cuidado prenatal.Sociedad Peruana de Obstetricia y Ginecología2025-11-13info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttps://ginecologiayobstetricia.pe/index.php/RPGO/article/view/277310.31403/rpgo.v71i2790The Peruvian Journal of Gynecology and Obstetrics ; Vol. 71 No. 2 (2025)Revista Peruana de Ginecología y Obstetricia; Vol. 71 Núm. 2 (2025)2304-51322304-512410.31403/rpgo.v71ireponame:Revista Peruana de Ginecología y Obstetriciainstname:Sociedad Peruana de Obstetricia y Ginecologíainstacron:SPOGspaenghttps://ginecologiayobstetricia.pe/index.php/RPGO/article/view/2773/3053https://ginecologiayobstetricia.pe/index.php/RPGO/article/view/2773/3054https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:ginecologiayobstetricia.pe:article/27732025-11-28T23:25:18Z |
| score |
13.411838 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).